Automate Your Wheel Strategy on CVS
With Tiblio's Option Bot, you can configure your own wheel strategy including CVS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CVS
- Rev/Share 305.4036
- Book/Share 61.2567
- PB 1.3501
- Debt/Equity 1.0691
- CurrentRatio 0.8034
- ROIC 0.0353
- MktCap 104662292465.0
- FreeCF/Share 3.7757
- PFCF 21.8959
- PE 23.0568
- Debt/Assets 0.3202
- DivYield 0.0322
- ROE 0.0595
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 3
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | CVS | Goldman | -- | Buy | -- | $91 | Oct. 14, 2025 |
| Upgrade | CVS | UBS | Neutral | Buy | -- | $79 | Aug. 18, 2025 |
| Upgrade | CVS | Robert W. Baird | Neutral | Outperform | -- | $82 | Aug. 14, 2025 |
| Upgrade | CVS | Leerink Partners | Market Perform | Outperform | $55 | $75 | Feb. 13, 2025 |
| Upgrade | CVS | Cantor Fitzgerald | Neutral | Overweight | -- | -- | Feb. 12, 2025 |
| Upgrade | CVS | Edward Jones | Hold | Buy | -- | -- | Jan. 30, 2025 |
| Upgrade | CVS | Deutsche Bank | Hold | Buy | -- | $66 | Dec. 3, 2024 |
| Upgrade | CVS | Barclays | Equal Weight | Overweight | $63 | $82 | Oct. 10, 2024 |
| Upgrade | CVS | TD Cowen | Hold | Buy | $59 | $85 | Oct. 4, 2024 |
News
CVS Expands Its Nationwide Care Network With Rite Aid Acquisition
Published: October 17, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Pharmacy completes the Rite Aid deal, adding 63 stores, 626 pharmacies and nine million patients to its national care network.
Read More
Should You Add CVS Health Stock to Your Portfolio Before Q3 Earnings?
Published: October 16, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health prepares Q3 results, with pharmacy performance and Aetna's progress in focus for investors.
Read More
Here's Why CVS Health (CVS) is a Strong Momentum Stock
Published: October 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Are Medical Stocks Lagging CVS Health (CVS) This Year?
Published: October 16, 2025 by: Zacks Investment Research
Sentiment: Negative
Here is how CVS Health (CVS) and Alignment Healthcare (ALHC) have performed compared to their sector so far this year.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: October 16, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Read More
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
5 Low Price-to-Book Stocks Worth Considering in October
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
STNE, CVS, KT, PAGS and ARW are five low price-to-book stocks that combine value appeal with solid growth potential.
Read More
CVS Health Completes Purchase Of Rite Aids, Adds 9 Million Customers
Published: October 15, 2025 by: Forbes
Sentiment: Positive
CVS Health has completed the acquisition of 63 Rite Aid stores in Idaho, Oregon and Washington and prescription files across 15 states that served more than 9 million customers, the drugstore chain said Wednesday.
Read More
CVS Health Corporation (CVS) Hits Fresh High: Is There Still Room to Run?
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Jim Cramer's top 10 things to watch in the stock market Tuesday
Published: October 14, 2025 by: CNBC
Sentiment: Negative
Stock futures fell Tuesday as trade tensions between the U.S. and China intensified.
Read More
CVS' Aetna Wins Big on 2026 MA Star Ratings: How to Play the Stock?
Published: October 13, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS' Aetna shines in 2026 Medicare Star Ratings, with more than 81% of members in four-star plans, fueling a 73.5% YTD stock surge and strong investor momentum.
Read More
CVS Health's Aetna Advances Initiative to Curb Hospital Readmissions
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS company, Aetna, expands its Aetna Clinical Collaboration program to 10 hospitals, aiming to cut readmissions and ease hospital workloads.
Read More
CVS Health (CVS) Is Considered a Good Investment by Brokers: Is That True?
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
Here's Why CVS Health (CVS) is a Strong Value Stock
Published: October 07, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
CVS Health to hold third quarter 2025 earnings conference call
Published: September 30, 2025 by: PRNewsWire
Sentiment: Neutral
WOONSOCKET, R.I. , Sept. 30, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, October 29 th, 2025, at 8:00 a.m.
Read More
CVS Health Gains as Revenue Grows, Dividend Remains Strong
Published: September 25, 2025 by: MarketBeat
Sentiment: Positive
One of the best ways for any investor to lock in additional portfolio upside is to start exploring areas where few others are willing to venture, especially when those are the least popular ones in the entire market.
Read More
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term
Published: September 25, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Published: September 25, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
CVS Health Drives Drug Affordability by Promoting Competition
Published: September 23, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS strengthens Caremark's PBM edge with formulary shifts, new partnerships and cost-saving wins for clients.
Read More
CVS unit Omnicare files for bankruptcy to resolve litigation
Published: September 22, 2025 by: Reuters
Sentiment: Negative
Omnicare, a subsidiary of health insurer CVS Health , said on Monday it has filed for bankruptcy to resolve issues related to its recent litigation in the U.S. District Court for the Southern District of New York.
Read More
Omnicare Initiates Voluntary Chapter 11 Process
Published: September 22, 2025 by: PRNewsWire
Sentiment: Neutral
Company Intends to Use Process to Implement a Standalone Restructuring or Sale Strategy Remains Focused on Delivering Safe and Reliable Pharmacy Services to All Customers WOONSOCKET, R.I. , Sept. 22, 2025 /PRNewswire/ -- Omnicare, LLC, a subsidiary of CVS Health (NYSE: CVS), today announced it has initiated a voluntary court-supervised Chapter 11 process to resolve issues related to its recent litigation in the U.S. District Court for the Southern District of New York.
Read More
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
CVS Health Steps Up to Bolster Oak Street as Cost Pressures Mount
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS trims its outlook as Oak Street faces rising medical costs, but new leadership and tech upgrades aim for steady growth.
Read More
CVS vs. EVH: Which Value-Based Care Stock Deserves Investor Attention?
Published: September 17, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS shows revenue growth and raised guidance, while EVH faces revenue declines but pursues oncology deals and efficiency gains.
Read More
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Published: September 11, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
CVS Health Makes Headway in Stabilizing Aetna: What's Driving It?
Published: September 11, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS makes progress in stabilizing Aetna with leadership, risk management and operational changes.
Read More
Stock Of The Day: Is CVS Headed Higher?
Published: September 09, 2025 by: Benzinga
Sentiment: Positive
CVS Health Corporation CVS is trading higher on Tuesday. This follows yesterday's sell-off of almost 5%.
Read More
Wall Street Analysts See CVS Health (CVS) as a Buy: Should You Invest?
Published: September 09, 2025 by: Zacks Investment Research
Sentiment: Neutral
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read More
CVS Health Trades Cheaper Than Industry: How to Play the Stock?
Published: September 08, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS' diversified model, digital push and Aetna stabilization highlight a compelling investment story.
Read More
About CVS Health Corporation (CVS)
- IPO Date 1996-11-20
- Website https://www.cvshealth.com
- Industry Medical - Healthcare Plans
- CEO J. David Joyner CEBS
- Employees 219000